<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://www.iongenomics.bio/p/maximal-cancer-diagnostics-with-sid</loc><news:news><news:publication><news:name>Ion Genomics</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-26T16:23:24+00:00</news:publication_date><news:title>Going "Founder Mode" on Cancer with Sid Sijbrandij and Jacob Stern</news:title></news:news></url><url><loc>https://www.iongenomics.bio/p/boehringer-ingelheim-immunai-ink</loc><news:news><news:publication><news:name>Ion Genomics</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-25T21:10:02+00:00</news:publication_date><news:title>Boehringer Ingelheim, Immunai Ink $15M Collaboration to Analyze T-cells</news:title></news:news></url><url><loc>https://www.iongenomics.bio/p/germanys-merck-to-buy-bio-techne</loc><news:news><news:publication><news:name>Ion Genomics</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-25T21:00:07+00:00</news:publication_date><news:title>Germany’s Merck to Buy Bio-Techne for $11.3 Billion</news:title></news:news></url><url><loc>https://www.iongenomics.bio/p/nateras-signatera-wins-first-mrd</loc><news:news><news:publication><news:name>Ion Genomics</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-24T20:04:32+00:00</news:publication_date><news:title>Natera's Signatera Wins First MRD Approval in Japan for Colorectal Cancer</news:title></news:news></url></urlset>